Provided by Tiger Fintech (Singapore) Pte. Ltd.

COYA THERAPEUTICS INC

5.71
+0.45008.56%
Volume:181.99K
Turnover:1.02M
Market Cap:95.50M
PE:-5.85
High:5.92
Open:5.19
Low:5.06
Close:5.26
Loading ...

Company Profile

Company Name:
COYA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
8
Office Location:
5850 San Felipe St.,Suite 500,Houston,Texas,United States
Zip Code:
77057
Fax:
- -
Introduction:
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a low-dose interleukin 2 Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an antigen directed Treg-derived exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.

Directors

Name
Position
Howard Berman
Chief Executive Officer,Director,Chairman
Anabella Villalobos
Director
Ann Lee
Director
Dov Goldstein
Director

Shareholders

Name
Position
Howard Berman
Chief Executive Officer,Director,Chairman
David Snyder
Chief Financial Officer, Chief Operating Officer
Adrian Hepner
President, Chief Medical Officer